Equities

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc

Actions
  • Price (EUR)35.20
  • Today's Change1.20 / 3.53%
  • Shares traded0.00
  • 1 Year change+43.09%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 07:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue608667580
OPERATING EXPENSES
Cost of revenue total848775
Selling, general and admin. expenses, total336377282
Depreciation/amortization828330
Unusual expense(income)20--22
Other operating expenses, total(1.52)(0.51)(6.53)
Total operating expense613621494
Operating income(5.27)4686
Other, net(0.56)(2.42)(3.73)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes2.776173
Provision for income taxes1.450.0320
Net income after taxes1.326153
Minority interest------
Net income before extra. Items1.326153
Total extraordinary items------
Net income1.326153
Inc.avail. to common excl. extra. Items1.326153
Inc.avail. to common incl. extra. Items1.326153
EPS RECONCILIATION
Basic/primary weighted average shares555453
Basic/primary eps excl. extra items0.021.131.01
Basic/primary eps incl. extra items0.021.131.01
Dilution adjustment--3.56--
Diluted weighted average shares566254
Diluted eps excl. extra items0.021.040.98
Diluted eps incl. extra items0.021.040.98
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock00--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1.854.6520
SUPPLEMENTAL INCOME
Depreciation, supplemental2.503.002.61
Total special items20--22
NORMALISED INCOME
Normalized income before taxes236195
Effect of special items on income taxes11--6.02
Income tax excluding impact of special items120.0326
Normalized income after tax116170
Normalized income avail. to common116170
Basic normalized EPS0.201.131.31
Diluted normalized EPS0.201.041.28
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.